{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:40:10Z","timestamp":1574383210182},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s42000-018-0083-8","type":"article-journal","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T21:57:02Z","timestamp":1542923822000},"page":"573-579","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":"Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment","prefix":"10.1007","volume":"17","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Polyzois","family":"Makras","sequence":"additional","affiliation":[]},{"given":"Gerhard","family":"Hawa","sequence":"additional","affiliation":[]},{"given":"Linda","family":"Sonnleitner","sequence":"additional","affiliation":[]},{"given":"Albert","family":"Missbichler","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Doulberis","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"issue":"8","key":"83_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.metabol.2015.12.009","volume":"65","author":"SA Polyzos","year":"2016","unstructured":"Polyzos SA, Mantzoros CS (2016) Nonalcoholic fatty future disease. Metabolism 65(8):1007\u20131016. \n                    https:\/\/doi.org\/10.1016\/j.metabol.2015.12.009","journal-title":"Metabolism"},{"issue":"14","key":"83_CR2","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1080\/14656566.2016.1225727","volume":"17","author":"G Mintziori","year":"2016","unstructured":"Mintziori G, Polyzos SA (2016) Emerging and future therapies for nonalcoholic steatohepatitis in adults. Expert Opin Pharmacother 17(14):1937\u20131946. \n                    https:\/\/doi.org\/10.1080\/14656566.2016.1225727","journal-title":"Expert Opin Pharmacother"},{"key":"83_CR3","doi-asserted-by":"publisher","first-page":"2784537","DOI":"10.1155\/2018\/2784537","volume":"2018","author":"B Li","year":"2018","unstructured":"Li B, Zhang C, Zhan YT (2018) Nonalcoholic fatty liver disease cirrhosis: a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis. Can J Gastroenterol Hepatol 2018:2784537. \n                    https:\/\/doi.org\/10.1155\/2018\/2784537","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"6","key":"83_CR4","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","volume":"59","author":"EASL\u2013EASD\u2013EASO","year":"2016","unstructured":"EASL\u2013EASD\u2013EASO (2016) EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Diabetologia 59(6):1121\u20131140. \n                    https:\/\/doi.org\/10.1007\/s00125-016-3902-y","journal-title":"Diabetologia"},{"issue":"12","key":"83_CR5","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/dom.12989","volume":"19","author":"SA Polyzos","year":"2017","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS, Polymerou V, Katsinelos P (2017) Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial. Diabetes Obes Metab 19(12):1805\u20131809. \n                    https:\/\/doi.org\/10.1111\/dom.12989","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"83_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/1470320311402110","volume":"12","author":"SA Polyzos","year":"2011","unstructured":"Polyzos SA, Kountouras J, Zafeiriadou E, Patsiaoura K, Katsiki E, Deretzi G, Zavos C, Tsarouchas G, Rakitzi P, Slavakis A (2011) Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease. J Renin-Angiotensin-Aldosterone Syst 12(4):498\u2013503. \n                    https:\/\/doi.org\/10.1177\/1470320311402110","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"4","key":"83_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.biocel.2011.01.007","volume":"43","author":"C Krause","year":"2011","unstructured":"Krause C, Guzman A, Knaus P (2011) Noggin. Int J Biochem Cell Biol 43(4):478\u2013481. \n                    https:\/\/doi.org\/10.1016\/j.biocel.2011.01.007","journal-title":"Int J Biochem Cell Biol"},{"key":"83_CR8","doi-asserted-by":"publisher","first-page":"31949","DOI":"10.1038\/srep31949","volume":"6","author":"D Costamagna","year":"2016","unstructured":"Costamagna D, Mommaerts H, Sampaolesi M, Tylzanowski P (2016) Noggin inactivation affects the number and differentiation potential of muscle progenitor cells in vivo. Sci Rep 6:31949. \n                    https:\/\/doi.org\/10.1038\/srep31949","journal-title":"Sci Rep"},{"key":"83_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-nutr-071813-105646","volume":"34","author":"NL Parrow","year":"2014","unstructured":"Parrow NL, Fleming RE (2014) Bone morphogenetic proteins as regulators of iron metabolism. Annu Rev Nutr 34:77\u201394. \n                    https:\/\/doi.org\/10.1146\/annurev-nutr-071813-105646","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"83_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"72","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 72(3):299\u2013314","journal-title":"Curr Mol Med"},{"issue":"3","key":"83_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00535-016-1237-6","volume":"52","author":"T Hasebe","year":"2017","unstructured":"Hasebe T, Tanaka H, Sawada K, Nakajima S, Ohtake T, Fujiya M, Kohgo Y (2017) Bone morphogenetic protein-binding endothelial regulator of liver sinusoidal endothelial cells induces iron overload in a fatty liver mouse model. J Gastroenterol 52(3):341\u2013351. \n                    https:\/\/doi.org\/10.1007\/s00535-016-1237-6","journal-title":"J Gastroenterol"},{"issue":"1","key":"83_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12072-017-9841-y","volume":"12","author":"P Chen","year":"2018","unstructured":"Chen P, Luo Q, Huang C, Gao Q, Li L, Chen J, Chen B, Liu W, Zeng W, Chen Z (2018) Pathogenesis of non-alcoholic fatty liver disease mediated by YAP. Hepatol Int 12(1):26\u201336. \n                    https:\/\/doi.org\/10.1007\/s12072-017-9841-y","journal-title":"Hepatol Int"},{"issue":"8","key":"83_CR13","doi-asserted-by":"publisher","first-page":"e0182932","DOI":"10.1371\/journal.pone.0182932","volume":"12","author":"KJ Belongie","year":"2017","unstructured":"Belongie KJ, Ferrannini E, Johnson K, Andrade-Gordon P, Hansen MK, Petrie JR (2017) Identification of novel biomarkers to monitor beta-cell function and enable early detection of type 2 diabetes risk. PLoS One 12(8):e0182932. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0182932","journal-title":"PLoS One"},{"issue":"2","key":"83_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s42000-018-0041-5","volume":"17","author":"BS Yurekli","year":"2018","unstructured":"Yurekli BS, Kocabas GU, Aksit M, Kutbay NO, Suner A, Yurekli I, Cakir H, Bozkaya G, Cetinkalp S (2018) The low levels of bone morphogenic protein-4 and its antagonist noggin in type 2 diabetes. Hormones (Athens) 17(2):247\u2013253. \n                    https:\/\/doi.org\/10.1007\/s42000-018-0041-5","journal-title":"Hormones (Athens)"},{"issue":"4","key":"83_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","volume":"46","author":"SA Polyzos","year":"2012","unstructured":"Polyzos SA, Kountouras J, Zavos C, Deretzi G (2012) Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. J Clin Gastroenterol 46(4):272\u2013284. \n                    https:\/\/doi.org\/10.1097\/MCG.0b013e31824587e0","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"83_CR16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S1665-2681(19)31316-X","volume":"12","author":"S Polyzos","year":"2013","unstructured":"Polyzos S, Kountouras J, Papatheodorou A, Katsiki E, Patsiaoura K, Zafeiriadou E, Zavos C, Papadopoulou E, Terpos E (2013) Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease - introduction of CHA index. Ann Hepatol 12(5):749\u2013757","journal-title":"Ann Hepatol"},{"key":"83_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ab.2018.03.002","volume":"549","author":"G Hawa","year":"2018","unstructured":"Hawa G, Sonnleitner L, Missbichler A, Prinz A, Bauer G, Mauracher C (2018) Single step, direct fluorescence immunoassays based on metal enhanced fluorescence (MEF-FIA) applicable as micro plate-, array-, multiplexing- or point of care-format. Anal Biochem 549:39\u201344. \n                    https:\/\/doi.org\/10.1016\/j.ab.2018.03.002","journal-title":"Anal Biochem"},{"issue":"6","key":"83_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van NM, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313\u20131321","journal-title":"Hepatology"},{"issue":"15","key":"83_CR19","doi-asserted-by":"publisher","first-page":"12241","DOI":"10.1074\/jbc.M111.293613","volume":"287","author":"A Sawant","year":"2012","unstructured":"Sawant A, Chanda D, Isayeva T, Tsuladze G, Garvey WT, Ponnazhagan S (2012) Noggin is novel inducer of mesenchymal stem cell adipogenesis: implications for bone health and obesity. J Biol Chem 287(15):12241\u201312249. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.293613","journal-title":"J Biol Chem"},{"issue":"5","key":"83_CR20","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.2337\/db11-1419","volume":"61","author":"B Gustafson","year":"2012","unstructured":"Gustafson B, Smith U (2012) The WNT inhibitor Dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 61(5):1217\u20131224. \n                    https:\/\/doi.org\/10.2337\/db11-1419","journal-title":"Diabetes"},{"issue":"6326","key":"83_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1126\/science.aai8792","volume":"355","author":"MV Plikus","year":"2017","unstructured":"Plikus MV, Guerrero-Juarez CF, Ito M, Li YR, Dedhia PH, Zheng Y, Shao M, Gay DL, Ramos R, Hsi TC, Oh JW, Wang X, Ramirez A, Konopelski SE, Elzein A, Wang A, Supapannachart RJ, Lee HL, Lim CH, Nace A, Guo A, Treffeisen E, Andl T, Ramirez RN, Murad R, Offermanns S, Metzger D, Chambon P, Widgerow AD, Tuan TL, Mortazavi A, Gupta RK, Hamilton BA, Millar SE, Seale P, Pear WS, Lazar MA, Cotsarelis G (2017) Regeneration of fat cells from myofibroblasts during wound healing. Science 355(6326):748\u2013752. \n                    https:\/\/doi.org\/10.1126\/science.aai8792","journal-title":"Science"},{"issue":"5","key":"83_CR22","doi-asserted-by":"publisher","first-page":"H747","DOI":"10.1152\/ajpheart.00825.2012","volume":"305","author":"M Koga","year":"2013","unstructured":"Koga M, Engberding N, Dikalova AE, Chang KH, Seidel-Rogol B, Long JS, Lassegue B, Jo H, Griendling KK (2013) The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db\/db mice. Am J Physiol Heart Circ Physiol 305(5):H747\u2013H755. \n                    https:\/\/doi.org\/10.1152\/ajpheart.00825.2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"83_CR23","first-page":"1137","volume":"18","author":"W Zhang","year":"2015","unstructured":"Zhang W, Yu Z, Deng F (2015) The role of noggin in regulation of high glucose-induced apoptosis and insulin secretion in INS-1 rat beta cells. Iran J Basic Med Sci 18(11):1137\u20131142","journal-title":"Iran J Basic Med Sci"},{"issue":"8","key":"83_CR24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1210\/me.2014-1313","volume":"29","author":"JY Youn","year":"2015","unstructured":"Youn JY, Zhou J, Cai H (2015) Bone morphogenic protein 4 mediates NOX1-dependent eNOS uncoupling, endothelial dysfunction, and COX2 induction in type 2 diabetes mellitus. Mol Endocrinol 29(8):1123\u20131133. \n                    https:\/\/doi.org\/10.1210\/me.2014-1313","journal-title":"Mol Endocrinol"},{"issue":"1","key":"83_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1161\/atvbaha.113.302696","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Liu J, Tian XY, Wong WT, Chen Y, Wang L, Luo J, Cheang WS, Lau CW, Kwan KM, Wang N, Yao X, Huang Y (2014) Inhibition of bone morphogenic protein 4 restores endothelial function in db\/db diabetic mice. Arterioscler Thromb Vasc Biol 34(1):152\u2013159. \n                    https:\/\/doi.org\/10.1161\/atvbaha.113.302696","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"83_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1006\/dbio.2002.0779","volume":"250","author":"W Balemans","year":"2002","unstructured":"Balemans W, Van Hul W (2002) Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250(2):231\u2013250","journal-title":"Dev Biol"},{"issue":"24","key":"83_CR27","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1161\/CIRCULATIONAHA.106.611822","volume":"113","author":"S Miriyala","year":"2006","unstructured":"Miriyala S, Gongora Nieto MC, Mingone C, Smith D, Dikalov S, Harrison DG, Jo H (2006) Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113(24):2818\u20132825. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.611822","journal-title":"Circulation"},{"issue":"4","key":"83_CR28","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.athoracsur.2012.12.028","volume":"95","author":"J Hu","year":"2013","unstructured":"Hu J, Liu J, Kwok MW, Wong RH, Huang Y, Wan S (2013) Bone morphogenic protein-4 contributes to venous endothelial dysfunction in patients with diabetes undergoing coronary revascularization. Ann Thorac Surg 95(4):1331\u20131339. \n                    https:\/\/doi.org\/10.1016\/j.athoracsur.2012.12.028","journal-title":"Ann Thorac Surg"},{"key":"83_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.gene.2017.06.051","volume":"627","author":"V Olsavszky","year":"2017","unstructured":"Olsavszky V, Ulbrich F, Singh S, Diett M, Sticht C, Schmid CD, Zierow J, Wohlfeil SA, Schledzewski K, Dooley S, Gaitantzi H, Breitkopf-Heinlein K, Geraud C, Goerdt S, Koch PS (2017) GATA4 and LMO3 balance angiocrine signaling and autocrine inflammatory activation by BMP2 in liver sinusoidal endothelial cells. Gene 627:491\u2013499. \n                    https:\/\/doi.org\/10.1016\/j.gene.2017.06.051","journal-title":"Gene"},{"issue":"6","key":"83_CR30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1159\/000350116","volume":"31","author":"S Wang","year":"2013","unstructured":"Wang S, Zhou G, Shu G, Wang L, Zhu X, Gao P, Xi Q, Zhang Y, Yuan L, Jiang Q (2013) Glucose utilization, lipid metabolism and BMP-Smad signaling pathway of porcine intramuscular preadipocytes compared with subcutaneous preadipocytes. Cell Physiol Biochem 31(6):981\u2013996. \n                    https:\/\/doi.org\/10.1159\/000350116","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"83_CR31","first-page":"127","volume":"13","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in nonalcoholic fatty liver disease. Hippokratia 13(2):127","journal-title":"Hippokratia"},{"issue":"1","key":"83_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/hep.29897","volume":"68","author":"SA Polyzos","year":"2018","unstructured":"Polyzos SA, Kountouras J, Anastasiadis S, Doulberis M, Katsinelos P (2018) Nonalcoholic fatty liver disease: is it time for combination treatment and a diabetes-like approach? Hepatology 68(1):389. \n                    https:\/\/doi.org\/10.1002\/hep.29897","journal-title":"Hepatology"},{"issue":"1","key":"83_CR33","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3390\/antiox7010012","volume":"7","author":"H Hadi El","year":"2018","unstructured":"El Hadi H, Vettor R, Rossato M (2018) Vitamin E as a treatment for nonalcoholic fatty liver disease: reality or myth? Antioxidants (Basel) 7(1):E12. \n                    https:\/\/doi.org\/10.3390\/antiox7010012","journal-title":"Antioxidants (Basel)"}],"container-title":"Hormones","original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-018-0083-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0083-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0083-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:23:20Z","timestamp":1574382200000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":33,"journal-issue":{"published-print":{"date-parts":[[2018,12]]},"issue":"4"},"alternative-id":["83"],"URL":"http:\/\/dx.doi.org\/10.1007\/s42000-018-0083-8","relation":{"cites":[]},"ISSN":["1109-3099","2520-8721"],"subject":["Endocrinology, Diabetes and Metabolism","General Medicine"],"container-title-short":"Hormones","assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided informed consent at baseline. The study protocol was in accordance with the Declaration of Helsinki and was approved by the ethics committee of the Medical School, Aristotle University of Thessaloniki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"G. Hawa, L. Sonnleitner, and A. Missbichler are employees of FIANOSTICS GmbH, Wiener Neustadt, Austria. All other authors have no potential conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}